Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Terns Pharmaceuticals, Inc. (TERN)

Compare
2.3300
-0.1600
(-6.43%)
At close: April 3 at 4:00:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
--
--
1,000
Operating Expense
101,871
101,871
102,558
62,029
50,860
Operating Income
-101,871
-101,871
-102,558
-62,029
-49,860
Net Non Operating Interest Income Expense
13,289
13,289
12,901
2,110
170
Other Income Expense
-11
-11
-314
-68
40
Pretax Income
-88,593
-88,593
-89,971
-59,987
-49,650
Tax Provision
260
260
239
358
508
Net Income Common Stockholders
-88,853
-88,853
-90,210
-60,345
-50,158
Diluted NI Available to Com Stockholders
-88,853
-88,853
-90,210
-60,345
-50,158
Basic EPS
-1.18
-1.12
-1.27
-1.67
-2.21
Diluted EPS
-1.18
-1.12
-1.27
-1.67
-2.21
Basic Average Shares
74,762.1370
79,507.4740
71,259.2390
36,033.0450
22,705.9480
Diluted Average Shares
74,762.1370
79,507.4740
71,259.2390
36,033.0450
22,705.9480
Total Operating Income as Reported
-101,871
-101,871
-102,558
-62,029
-49,860
Total Expenses
101,871
101,871
102,558
62,029
50,860
Net Income from Continuing & Discontinued Operation
-88,853
-88,853
-90,210
-60,345
-50,158
Normalized Income
-88,853
-88,853
-90,210
-60,345
-50,158
Interest Income
13,289
13,289
12,901
2,110
170
Net Interest Income
13,289
13,289
12,901
2,110
170
EBIT
-101,871
-101,871
-102,558
-62,029
-49,860
EBITDA
-100,975
-100,975
-101,677
-60,997
-49,348
Reconciled Depreciation
896
896
881
1,032
512
Net Income from Continuing Operation Net Minority Interest
-88,853
-88,853
-90,210
-60,345
-50,158
Normalized EBITDA
-100,975
-100,975
-101,677
-60,997
-49,348
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
12/31/2021 - 2/5/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ALT Altimmune, Inc.
4.4600
-6.69%
 
GPCR Structure Therapeutics Inc.
16.33
-3.66%
 
AKRO Akero Therapeutics, Inc.
39.99
-4.67%
 
MDGL Madrigal Pharmaceuticals, Inc.
327.10
-2.24%
 
ETNB 89bio, Inc.
6.86
-4.59%
 
VKTX Viking Therapeutics, Inc.
24.22
-5.69%
 
IMUX Immunic, Inc.
1.0500
-5.41%
 
FDMT 4D Molecular Therapeutics, Inc.
2.8850
-12.04%
 
CRDF Cardiff Oncology, Inc.
2.8700
-4.65%
 
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.5635
+0.32%